Pfizer celebrates 175th anniversary with annual review

Pfizer released its Annual Review for 2024, marking its 175th anniversary. The report highlights the company's achievements and improvements over the past year, emphasizing its commitment to innovation and patient care. CEO Albert Bourla noted that Pfizer met or exceeded its five strategic goals, including leadership in oncology and enhancing shareholder value. The review also details financial performance and advancements in patient access and artificial intelligence. Pfizer's successful 2024 positions the company for future growth as it aims for its 200th anniversary. The review is available on Pfizer's website.